Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials - Université de Lille Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Frontiers of Radiation Therapy and Oncology Année : 2020

Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials

Résumé

We reviewed all fully published clinical trials assessing anti-angiogenic agents in sarcoma patients (last issue, January 13, 2020). Anti-angiogenic macromolecules (e.g., bevacizumab or ombrabulin) provide disappointing results. Many multikinase inhibitors have been assessed with non-randomized phase II trials with limited samples and without stratification according to histological subtypes, therefore interpretation of such trials is very challenging. On the contrary, pazopanib, regorafenib, and sorafenib have been assessed using double-blind placebo-controlled randomized phase II or phase III trials. Compared to placebo, sorafenib demonstrates activity in desmoid-type fibromatosis patients. Based on results of phase 3 trial, pazopanib had obtained approval for treatment of pretreated non-adipocytic soft tissue sarcoma. Regorafenib is currently assessed in several clinical settings and provides significant improvement of progression-free survival in pre-treated non-adipocytic soft tissue sarcoma and in advanced pretreated osteosarcoma. Multikinase inhibitors are a breakthrough in sarcoma management. Many trials are ongoing. Nevertheless, predictive factors are still missing.
Fichier principal
Vignette du fichier
fonc-10-594445.pdf (1.36 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04342009 , version 1 (22-12-2023)

Licence

Identifiants

Citer

Pierre-Yves Cren, Loïc Lebellec, Thomas Ryckewaert, Nicolas Penel. Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials. Frontiers of Radiation Therapy and Oncology, 2020, Frontiers of Radiation Therapy and Oncology, 10, ⟨10.3389/fonc.2020.594445⟩. ⟨hal-04342009⟩

Collections

UNIV-LILLE
2 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More